- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.09. | GlucoTrack Stock Rises 27% After Public Offering Announcement | 2 | RTTNews | ||
| 24.09. | Glucotrack prices $3.1M public offering | 3 | Seeking Alpha | ||
| 24.09. | Glucotrack prices $3.1 million public offering at $2.04/share | 1 | Investing.com | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 24.09. | Glucotrack platziert öffentliches Angebot über 3,1 Millionen US-Dollar zu 2,04 US-Dollar je Aktie | 2 | Investing.com Deutsch | ||
| 18.09. | Glucotrack: Direktor Paul V. Goode tritt wegen möglichem Interessenkonflikt zurück | 4 | Investing.com Deutsch | ||
| 18.09. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.09. | Glucotrack, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 11.09. | Glucotrack announces $11.5M financing | 1 | Seeking Alpha | ||
| 11.09. | Glucotrack secures $11.5M in convertible note financing | 1 | Investing.com | ||
| 09.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08. | Glucotrack announces 1-for-15 reverse stock split | 1 | Seeking Alpha | ||
| 27.08. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.08. | Glucotrack, Inc. Announces Reverse Stock Split | 275 | Business Wire | 1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack"... ► Artikel lesen | |
| 19.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.08. | Glucotrack regains Nasdaq compliance on equity requirement | 1 | Investing.com | ||
| 06.08. | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | 1 | pulse2.com | ||
| 05.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 17.07. | Glucotrack Gains Slightly on Bridge Financing Deal | - | Baystreet.ca |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,000 | +0,16 % | Eckert&Ziegler mit EILMELDUNG: Meine brandneue Prognose ändert einfach alles - Handeln Sie, bevor es zu spät ist! | ||
| TELADOC HEALTH | 5,178 | +5,70 % | Teladoc Aktie setzt Talfahrt fort: Chefjurist geht, Sorgen bleiben | ||
| SERNOVA BIOTHERAPEUTICS | 0,066 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| CERENOME | 1,342 | -6,42 % | Cerenome, Inc.: Cerenome Expects $1.55 Million in CNSide Third Quarter Gross Billings | Lead test on track for 200 million covered lives and beneficiaries by early 2027 after CMS meeting On track to launch expanded CNSide testing menu with multiple tests in Q4 2026 HOUSTON, Sept. 30... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,960 | -6,67 % | Atossa plans shareholder stake in potential PRV proceeds | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,050 | -5,97 % | XFRA L7T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIDOC HEALTH CORP.... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | +1,36 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,100 | +2,33 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUIDELORTHO | 10,960 | +14,62 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 206,60 | -0,29 % | Humanity Health Inc.; Quest Diagnostics: Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com | Individuals in the U.S. can now add Humanity Biological Age's lab-informed insights to select health profile tests purchased through Quest's consumer-initiated testing platformLONDON, Aug.... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,110 Euro und damit -7,50 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.